Atomwise

Founded: 2012 · San Francisco, California, US · 51-200 employees · Private

About Atomwise

Atomwise is a biotechnology company that leverages artificial intelligence (AI) and machine learning to accelerate drug discovery and development. They invented the use of deep learning for structure-based drug discovery and are developing a pipeline of small-molecule drug candidates advancing into preclinical studies.

Company Details

Website: https://www.atomwise.com
Funding: Series C
Total Raised: $219M
LinkedIn: https://www.linkedin.com/company/atomwise
GitHub: https://github.com/AtomwiseInc

Specializations

AI/ML
Drug Discovery
Biotechnology
Deep Learning
Pharmaceuticals

Products & Solutions (1)

Product	Category	Sub-Category	Description
AtomNet	research-development	Drug Discovery AI	AI-powered virtual screening for drug candidates

Notable Customers

Eli Lilly and Company
Bayer
Hansoh Pharmaceutical Group Co. Ltd.
Bridge Biotherapeutics Inc.
Sanofi
Charles River Labs
Merck
Abbvie
University of Toronto
SEngine Precision Medicine
Pfizer